Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 29251-29300 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06145919
Parent-Child Memory Study: Improving Future Thinking Among Mothers
NA
Recruiting
144 participants
Started: Feb 6, 2024 · Completed: Aug 31, 2025
1 condition
4 sponsors
1 location
NCT06062303
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
NA
Recruiting
180 participants
Started: Feb 6, 2024 · Completed: May 30, 2026
2 conditions
1 sponsor
1 location
NCT06262880
Dietary Supplementation on Gastrointestinal Barrier Function
NA
Recruiting
126 participants
Started: Feb 6, 2024 · Completed: Feb 6, 2025
1 condition
1 sponsor
1 location
NCT06158958
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
PHASE1
Recruiting
192 participants
Started: Feb 6, 2024 · Completed: Jan 31, 2028
1 condition
1 sponsor
18 locations
NCT06243263
Postoperative Pain After Bupivacaine Supplementation in Mandibular Fracture Surgery
PHASE4
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Mar 4, 2024
4 conditions
1 sponsor
2 locations
NCT05943665
MDMA for AUD/PTSD Comorbidity
PHASE2
Recruiting
18 participants
Started: Feb 6, 2024 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT06259279
High Impact Training to Patients with Prostate Cancer and Bone Metastases
NA
Recruiting
102 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06102330
Multicenter HomeVENT: Home Values and Experiences Navigation Track
NA
Recruiting
600 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2030
3 conditions
2 sponsors
4 locations
NCT06273761
Evaluation of Medication Management Service
NA
Recruiting
640 participants
Started: Feb 6, 2024 · Completed: May 1, 2027
6 conditions
10 sponsors
8 locations
NCT06247345
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
PHASE1
Recruiting
73 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
4 locations
NCT06152185
Mindfulness App Training for Cardiovascular Health
NA
Recruiting
105 participants
Started: Feb 6, 2024 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
NCT06777771
Effects of Reformer Pilates in Pregnant Women
NA
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
5 conditions
1 sponsor
1 location
NCT06883942
Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.
N/A
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT06751121
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
PHASE3
Recruiting
460 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT06586021
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
NA
Recruiting
25 participants
Started: Feb 6, 2024 · Completed: Nov 1, 2029
1 condition
1 sponsor
1 location
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
PHASE2
Recruiting
60 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2032
1 condition
2 sponsors
1 location
NCT06525168
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
PHASE1
Recruiting
82 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05868629
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
N/A
Recruiting
40 participants
Started: Feb 6, 2024 · Completed: May 4, 2028
1 condition
1 sponsor
6 locations
NCT06246110
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
PHASE2
Recruiting
70 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
39 locations
NCT06395922
Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy
NA
Recruiting
140 participants
Started: Feb 6, 2024 · Completed: Jun 1, 2024
3 conditions
1 sponsor
1 location
NCT06259513
Omission of Axillary Surgery in Breast Cancer Patients
NA
Recruiting
350 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2033
3 conditions
1 sponsor
1 location
NCT06238544
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE2
Recruiting
120 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT05542069
Measurement of the Diaphragm Loading During the Training With a IMT Device
N/A
Recruiting
10 participants
Started: Feb 6, 2024 · Completed: Mar 30, 2025
1 condition
1 sponsor
1 location
NCT06992986
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
N/A
Recruiting
50 participants
Started: Feb 6, 2024 · Completed: Jul 6, 2025
1 condition
1 sponsor
1 location
NCT06224933
Augmented Reality For MRI-Guided Interventions
NA
Recruiting
25 participants
Started: Feb 6, 2024 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT06225726
Elastographic Analysis of Urothelial Bladder Tumours
N/A
Recruiting
50 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2025
2 conditions
1 sponsor
1 location
NCT06377267
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
PHASE2
Recruiting
100 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06017856
Physical Exercise and Nutrition in Functional Gastrointestinal Disorders in Obese Children
N/A
Recruiting
180 participants
Started: Feb 6, 2024 · Completed: Nov 30, 2024
2 conditions
1 sponsor
1 location
NCT06112704
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
PHASE2
Recruiting
220 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
21 locations
NCT05711615
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
PHASE1
Recruiting
30 participants
Started: Feb 6, 2024 · Completed: May 3, 2026
12 conditions
1 sponsor
16 locations
NCT06031714
Fetal Cell Receptors Repertoire
NA
Recruiting
160 participants
Started: Feb 6, 2024 · Completed: Feb 1, 2027
5 conditions
2 sponsors
1 location
NCT06138509
Peripheral Serotonin and Albinism
N/A
Recruiting
160 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT06222723
LAssa Fever Adjunct Treatment With DEXamethasone
PHASE2
Recruiting
42 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06118697
Feasibility of Aerodigestive Stimulation Therapy Trial
NA
Recruiting
40 participants
Started: Feb 5, 2024 · Completed: Nov 1, 2027
1 condition
1 sponsor
1 location
NCT06562478
Effects of Zazen Meditation in Patients With Acute Myocardial Infarction - Randomized Clinical Trial
NA
Recruiting
44 participants
Started: Feb 5, 2024 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT06257355
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
PHASE1
Recruiting
20 participants
Started: Feb 5, 2024 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT06257030
The AMARA (As Much As Reasonably Achievable) Study
N/A
Recruiting
100 participants
Started: Feb 5, 2024 · Completed: Feb 5, 2027
1 condition
1 sponsor
1 location
NCT06286462
Evaluation of the Cancer Tracking System (CATSystem)
NA
Recruiting
6,600 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2028
1 condition
5 sponsors
10 locations
NCT05910827
Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers
PHASE1/PHASE2
Recruiting
98 participants
Started: Feb 5, 2024 · Completed: Mar 1, 2026
5 conditions
2 sponsors
20 locations
NCT06229158
Assessment of the Quality and Sexual Health Needs of Patients with Advanced-stage Cancer
N/A
Recruiting
120 participants
Started: Feb 5, 2024 · Completed: Apr 30, 2025
2 conditions
1 sponsor
3 locations
NCT05875571
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
PHASE4
Recruiting
18 participants
Started: Feb 5, 2024 · Completed: Jun 30, 2025
4 conditions
1 sponsor
1 location
NCT06260215
Recovery Kinetics Following a Soccer Training in Middle-aged Males
NA
Recruiting
11 participants
Started: Feb 5, 2024 · Completed: Mar 9, 2024
1 condition
1 sponsor
1 location
NCT06695559
Non-surgical Treatment of Peri-implantitis Using Chitosan Brush and Tetracycline Slurry
PHASE4
Recruiting
40 participants
Started: Feb 5, 2024 · Completed: Feb 5, 2025
2 conditions
1 sponsor
1 location
NCT06146855
Amnion Membrane Versus DFGG Using the Tunneling Technique in Management of Gingival Recession Defects.
NA
Recruiting
22 participants
Started: Feb 5, 2024 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT06002217
Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF)
NA
Recruiting
80 participants
Started: Feb 5, 2024 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06191744
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
PHASE3
Recruiting
1,095 participants
Started: Feb 5, 2024 · Completed: Nov 30, 2037
1 condition
2 sponsors
249 locations
NCT05006404
Autus Valve Pivotal Study
NA
Recruiting
50 participants
Started: Feb 5, 2024 · Completed: Feb 29, 2036
1 condition
1 sponsor
12 locations
NCT05776056
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
PHASE4
Recruiting
70 participants
Started: Feb 5, 2024 · Completed: Mar 31, 2027
1 condition
1 sponsor
3 locations
NCT06288763
Nerve Transfer to Improve Function in High Level Tetraplegia
N/A
Recruiting
30 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2028
2 conditions
11 sponsors
9 locations
NCT06247670
Study of CMP-CPS-001 in Healthy Volunteers
PHASE1
Recruiting
96 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
583
584
585
586
587
588
589
More pages
1333
Next